Blueprint Medicines Corporation
USPTO PatentsView assignee record - 59 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Blueprint ranks #5,742 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 10 technology areas.
- #5,742
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (40.1/100)
- 17.2
- avg claims per patent
- -7%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5742 · US Corporation #5,742 · 59 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
- GRANTS-SMALL 59 grants
- UPPER-Q #5,742/49,997
- PHOTO-FINISH Banjo
- CPC-FOCUS A61P · 10 areas
- INNOV-PAR 40.1/100
- CLAIMS-RICH 17.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-FLAT -7% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Banjo Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Blueprint’s 40.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Blueprint
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Blueprint Medicines · this assignee
Blueprint Medicines · this assignee
40 score
- Copan Italia S p A · near
Copan Italia S p A · near
40 score
- Musculoskeletal… · near
Musculoskeletal… · near
40 score
- Nippon Steel &… · near
Nippon Steel &… · near
40 score
- Saurer Spinning… · near
Saurer Spinning… · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Blueprint's Innovation Score is 40.1/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Blueprint?
Each dot is one of Blueprint’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Blueprint’s own 17.2 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Blueprint's grants concentrate
Blueprint Medicines Corporation is a focused PatentsView assignee: 10 CPC subclasses with 81.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (13 grants) versus a trough of 2 in 2015. By volume, Blueprint sits between Bauerfeind AG and Conagra Foods RDM, Inc..
Blueprint's three-year grant acceleration
From 2019–2021 to 2022–2024, Blueprint Medicines Corporation moved from 24 to 16 grants (0.67x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Blueprint's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bauerfeind
Bauerfeind AG
59 patents
- Baylor Research I…
Baylor Research Institute
59 patents
- BP Exploration Op…
BP Exploration Operating Company Limited
59 patents
- Banjo
Banjo Corporation
59 patents
- Capsovision
Capsovision, Inc.
59 patents
- Ceramtec
Ceramtec GMBH
59 patents
- Cimpress Schweiz
Cimpress Schweiz GMBH
59 patents
- Conagra Foods RDM
Conagra Foods RDM, Inc.
59 patents
- Blueprint Medicin… ◀
Blueprint Medicines Corporation
59 patents
What this shows Blueprint holds 59 patents at rank #5,743, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Blueprint
By rank, the assignees closest to #5,743 in granted patent volume.
- Bauerfeind AG #5,739 · 59 patents
- Baylor Research Institute #5,740 · 59 patents
- BP Exploration Operating Company Limited #5,741 · 59 patents
- Banjo Corporation #5,742 · 59 patents
- Capsovision, Inc. #5,744 · 59 patents
- Ceramtec GMBH #5,745 · 59 patents
- Cimpress Schweiz GMBH #5,746 · 59 patents
- Conagra Foods RDM, Inc. #5,747 · 59 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Blueprint's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Blueprint, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Blueprint ranks #374 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Similar claim depth
Nearest assignees by average claims per patent (17.2 here).
Blueprint's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 3.4% |
| 2016 | 3 | 5.1% |
| 2017 | 2 | 3.4% |
| 2018 | 9 | 15.3% |
| 2019 | 13 | 22.0% |
| 2020 | 8 | 13.6% |
| 2021 | 3 | 5.1% |
| 2022 | 5 | 8.5% |
| 2023 | 3 | 5.1% |
| 2024 | 8 | 13.6% |
| 2025partial year | 3 | 5.1% |
Which technologies does Blueprint Medicines Corporation patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Blueprint Medicines Corporation's patent record in context - here's where to go next.
- Blueprint Medicines Corporation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 81.4% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #5,742 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Blueprint Medicines Corporation against Bauerfeind AG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.